These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1216091

  • 1. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR, Levy NL.
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract] [Full Text] [Related]

  • 2. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR, Gangal SG.
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT, Wagner H, Harris AW.
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M, Suit HD.
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL.
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract] [Full Text] [Related]

  • 14. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL, Luckenbach MW, Fischer BJ, Niederkorn JY.
    J Immunol; 1987 Jun 15; 138(12):4515-23. PubMed ID: 3108394
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF, Snell GD.
    Transplant Proc; 1973 Mar 15; 5(1):953-6. PubMed ID: 4572155
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J.
    Cancer Res; 1974 Nov 15; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.